133 related articles for article (PubMed ID: 16854964)
21. Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?
Baumann R; Depping R; Delaperriere M; Dunst J
Expert Rev Anticancer Ther; 2016 Jul; 16(7):751-8. PubMed ID: 27253509
[TBL] [Abstract][Full Text] [Related]
22. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
[TBL] [Abstract][Full Text] [Related]
23. Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.
Le QT
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S56-8. PubMed ID: 17848296
[No Abstract] [Full Text] [Related]
24. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
Beasley NJ; Leek R; Alam M; Turley H; Cox GJ; Gatter K; Millard P; Fuggle S; Harris AL
Cancer Res; 2002 May; 62(9):2493-7. PubMed ID: 11980639
[TBL] [Abstract][Full Text] [Related]
25. [Radioresistance parameters in head and neck cancers and methods to radiosensitize].
Biau J; Chautard E; Miroir J; Lapeyre M
Cancer Radiother; 2015 Aug; 19(5):337-46; quiz 360-1, 363. PubMed ID: 26119219
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study.
Kyzas PA; Stefanou D; Batistatou A; Agnantis NJ
Cancer Lett; 2005 Jul; 225(2):297-304. PubMed ID: 15978334
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia as a Biomarker and for Personalized Radiation Oncology.
Vordermark D; Horsman MR
Recent Results Cancer Res; 2016; 198():123-42. PubMed ID: 27318684
[TBL] [Abstract][Full Text] [Related]
30. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.
Overgaard J; Eriksen JG; Nordsmark M; Alsner J; Horsman MR;
Lancet Oncol; 2005 Oct; 6(10):757-64. PubMed ID: 16198981
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
33. Optimising the therapeutic ratio in head and neck cancer.
Eckert AW; Schubert J; Taubert H
Lancet Oncol; 2010 Jun; 11(6):511-2. PubMed ID: 20522377
[No Abstract] [Full Text] [Related]
34. [Molecular imaging of tumor hypoxia].
Huchet A; Fernandez P; Allard M; Belkacémi Y; Maire JP; Trouette R; Eimer S; Tourdias T; Loiseau H
Cancer Radiother; 2009 Dec; 13(8):747-57. PubMed ID: 19854090
[TBL] [Abstract][Full Text] [Related]
35. Implantable oxygen microelectrode suitable for medium-term investigations of post-surgical tissue hypoxia and changes in tumor tissue oxygenation produced by radiotherapy.
Burke TR; Johnson RJ; Krishnamsetty CB; Sako K; Karakousis C; Wojtas F
J Med; 1980; 11(5-6):339-51. PubMed ID: 6962823
[TBL] [Abstract][Full Text] [Related]
36. Impact of tumor hypoxia and anemia on radiation therapy outcomes.
Harrison LB; Chadha M; Hill RJ; Hu K; Shasha D
Oncologist; 2002; 7(6):492-508. PubMed ID: 12490737
[TBL] [Abstract][Full Text] [Related]
37. Development of an in silico stochastic 4D model of tumor growth with angiogenesis.
Forster JC; Douglass MJ; Harriss-Phillips WM; Bezak E
Med Phys; 2017 Apr; 44(4):1563-1576. PubMed ID: 28129434
[TBL] [Abstract][Full Text] [Related]
38. Optical spectroscopic sensing of tumor hypoxia.
Dadgar S; Troncoso JR; Rajaram N
J Biomed Opt; 2018 Jun; 23(6):1-6. PubMed ID: 29873205
[TBL] [Abstract][Full Text] [Related]
39. Novel imaging approaches to head and neck cancer.
Krohn KA; Yeuh B
Semin Oncol; 2008 Jun; 35(3):262-73. PubMed ID: 18544441
[TBL] [Abstract][Full Text] [Related]
40. Hyperbaric oxygen in the radiation treatment of head and neck cancers.
Sealy R
Radiother Oncol; 1991; 20 Suppl 1():75-9. PubMed ID: 2020773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
